Therapy Area - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/ The leading site for news and procurement in the pharmaceutical industry Wed, 17 Apr 2024 14:35:13 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.2 https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/01/cropped-Pharmaceutical-Technology-Favicon-150x150.png Therapy Area - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/therapy-area/ 32 32 Ultimovacs downsizes to funnel funds to cancer vaccine programme https://www.pharmaceutical-technology.com/news/ultimovacs-downsizes-to-funnel-funds-to-cancer-vaccine-programme/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2209421681.jpg Wed, 17 Apr 2024 11:07:21 +0000 https://www.pharmaceutical-technology.com/?p=297208 FDA halts Neumora’s schizophrenia drug trial over convulsions in rabbits https://www.pharmaceutical-technology.com/news/fda-halts-neumoras-schizophrenia-drug-trial-over-convulsions-in-rabbits/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2242616675.jpg Tue, 16 Apr 2024 10:09:59 +0000 https://www.pharmaceutical-technology.com/?p=296761 Norgine seeks approval for high-risk neuroblastoma treatment https://www.pharmaceutical-technology.com/news/norgine-high-risk-neuroblastoma/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/Norgine.jpg Tue, 16 Apr 2024 08:00:10 +0000 https://www.pharmaceutical-technology.com/news/norgine-high-risk-neuroblastoma/ Portage mulls company closure, pauses enrolment for lead clinical programme https://www.pharmaceutical-technology.com/news/portage-mulls-company-closure-pauses-enrolment-for-lead-clinical-programme/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2213945251-scaled.jpg Mon, 15 Apr 2024 12:58:55 +0000 https://www.pharmaceutical-technology.com/news/portage-mulls-company-closure-pauses-enrolment-for-lead-clinical-programme/ Sanofi advances NK cell engager to Phase II for blood cancer treatment https://www.pharmaceutical-technology.com/news/sanofi-advances-nk-cell-engager-to-phase-ii-for-blood-cancer-treatment/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2053426424.jpg Mon, 15 Apr 2024 11:07:45 +0000 https://www.pharmaceutical-technology.com/uncategorized/sanofi-advances-nk-cell-engager-to-phase-ii-for-blood-cancer-treatment/ Nigeria launches new 5-in-1 meningitis vaccine https://www.pharmaceutical-technology.com/news/nigeria-meningitis-vaccine-men5cv/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/Nigeria.jpg Mon, 15 Apr 2024 07:27:08 +0000 https://www.pharmaceutical-technology.com/news/nigeria-meningitis-vaccine-men5cv/ Candel wins FDA orphan drug designation for pancreatic cancer drug https://www.pharmaceutical-technology.com/news/candel-wins-fda-orphan-drug-designation-for-pancreatic-cancer-drug/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_1638621190.jpg Fri, 12 Apr 2024 14:22:15 +0000 https://www.pharmaceutical-technology.com/news/candel-wins-fda-orphan-drug-designation-for-pancreatic-cancer-drug/ Century secures $60m in stock sale and buys preclinical cell therapy biotech https://www.pharmaceutical-technology.com/news/century-secures-60m-in-stock-sale-and-buys-preclinical-cell-therapy-biotech/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2119416338-1.jpg Fri, 12 Apr 2024 13:50:52 +0000 https://www.pharmaceutical-technology.com/news/century-secures-60m-in-stock-sale-and-buys-preclinical-cell-therapy-biotech/ Eliem Therapeutics agrees to acquire Tenet https://www.pharmaceutical-technology.com/news/eliem-to-acquire-tenet/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/Eliem.jpg Fri, 12 Apr 2024 10:08:37 +0000 https://www.pharmaceutical-technology.com/news/eliem-to-acquire-tenet/ Novartis signs deal for Arvinas’ prostate cancer therapy https://www.pharmaceutical-technology.com/news/novartis-enters-deal-arvinas/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/novartis.jpg Fri, 12 Apr 2024 08:19:38 +0000 https://www.pharmaceutical-technology.com/news/novartis-enters-deal-arvinas/